SUCCESSFUL USE OF A DARUNAVIR/RITONAVIR IN FIVE PREGNANT WOMEN: PHARMACOKINETICS, EFFICACY AND SAFETY

被引：0
|
作者：
Ivanovic, J. [1 ]
Bellagamba, R. [1 ]
Tempestilli, M. [1 ]
Signore, F. [2 ]
Vallone, C. [2 ]
Pisani, G. [2 ]
Nicastri, E. [1 ]
Tommasi, C. [1 ]
Gallo, A. L. [1 ]
Fezza, R. [1 ]
Pucillo, L. P. [1 ]
Narciso, P. [1 ]
机构：
[1] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy
[2] San Camillo Forlanini Hosp, Dept Obstet & Gynaecol, Rome, Italy
来源：
INFECTION | 2011年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and Safety of Darunavir/Ritonavir in HIV-Infected Pregnant Women
    Khoo, Saye
    Peytavin, Gilles
    Burger, David
    Hill, Andrew
    Brown, Kimberley
    Moecklinghoff, Christiane
    La Porte, Charles
    Hadacek, Maria Blanca
    AIDS REVIEWS, 2017, 19 (01) : 16 - 23
  • [2] Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety
    Ivanovic, Jelena
    Bellagamba, Rita
    Nicastri, Emanuele
    Signore, Fabrizio
    Vallone, Cristina
    Tempestilli, Massimo
    Tommasi, Chiara
    Mazzitelli, Luisa
    Narciso, Pasquale
    AIDS, 2010, 24 (07) : 1083 - 1084
  • [3] Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents
    Blanche, Stephane
    Bologna, Rosa
    Cahn, Pedro
    Rugina, Sorin
    Flynn, Patricia
    Fortuny, Claudia
    Vis, Peter
    Sekar, Vanitha
    van Baelen, Ben
    Dierynck, Inge
    Spinosa-Guzman, Sabrina
    AIDS, 2009, 23 (15) : 2005 - 2013
  • [4] Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women
    Crauwels, H. M.
    Kakuda, T. N.
    Ryan, B.
    Zorrilla, C.
    Osiyemi, O. O.
    Yasin, S.
    Brown, K.
    Verboven, P.
    Hillewaert, V.
    Baugh, B.
    HIV MEDICINE, 2016, 17 (09) : 643 - 652
  • [5] Darunavir for use in pregnant women with HIV
    Pope, Robert, Jr.
    Kashuba, Angela
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (12) : 1317 - 1327
  • [6] Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV
    Momper, Jeremiah D.
    Wang, Jiajia
    Stek, Alice
    Shapiro, David E.
    Scott, Gwendolyn B.
    Paul, Mary E.
    Febo, Irma L.
    Burchett, Sandra
    Smith, Elizabeth
    Chakhtoura, Nahida
    Denson, Kayla
    Rungruengthanakit, Kittipong
    George, Kathleen
    Yang, Derek Z.
    Capparelli, Edmund, V
    Mirochnick, Mark
    Best, Brookie M.
    AIDS, 2021, 35 (08) : 1191 - 1199
  • [7] Transplacental passage of ritonavir-boosted darunavir in two pregnant women
    Ripamonti, D.
    Cattaneo, D.
    Cortinovis, M.
    Maggiolo, F.
    Suter, F.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2009, 20 (03) : 215 - 216
  • [8] Efficacy, safety and pharmacokinetics of 900/100 mg of darunavir/ritonavir once daily in treatment-experienced patients
    Curran, Adrian
    Gutirerrez, Mar
    Deig, Elisabet
    Mateo, Gracia
    Maria Lopez, Rosa
    Imaz, Arkaitz
    Crespo, Manuel
    Ocana, Inma
    Domingo, Pere
    Ribera, Esteban
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (10) : 2195 - 2203
  • [9] Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily
    Zorrilla, C. D.
    Wright, R.
    Osiyemi, O. O.
    Yasin, S.
    Baugh, B.
    Brown, K.
    Coate, B.
    Verboven, P.
    Mrus, J.
    Falcon, R.
    Kakuda, T. N.
    HIV MEDICINE, 2014, 15 (01) : 50 - 56
  • [10] Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial
    Girard, P. M.
    Antinori, A.
    Arribas, J. R.
    Ripamonti, D.
    Bicer, C.
    Netzle-Sveine, B.
    Hadacek, B.
    Moecklinghoff, C.
    HIV MEDICINE, 2017, 18 (01) : 5 - 12
12345